509 related articles for article (PubMed ID: 8091662)
1. A genetic selection method for the transfer of HSV-1 glycoprotein B mutations from plasmid to the viral genome: preliminary characterization of transdominance and entry kinetics of mutant viruses.
Desai P; Homa FL; Person S; Glorioso JC
Virology; 1994 Oct; 204(1):312-22. PubMed ID: 8091662
[TBL] [Abstract][Full Text] [Related]
2. Early region 3-replacement adenovirus recombinants are less pathogenic in cotton rats and mice than early region 3-deleted viruses.
Berencsi K; Uri A; Valyi-Nagy T; Valyi-Nagy I; Meignier B; Peretz FV; Rando RF; Plotkin SA; Gönczöl E
Lab Invest; 1994 Sep; 71(3):350-8. PubMed ID: 7933985
[TBL] [Abstract][Full Text] [Related]
3. Herpes simplex virus (HSV) glycoproteins B and K inhibit cell fusion induced by HSV syncytial mutants.
Hutchinson L; Graham FL; Cai W; Debroy C; Person S; Johnson DC
Virology; 1993 Oct; 196(2):514-31. PubMed ID: 8396800
[TBL] [Abstract][Full Text] [Related]
4. Resolution of genotypic and phenotypic properties of herpes simplex virus type 1 temperature-sensitive mutant (KOS) tsZ47: evidence for allelic complementation in the UL28 gene.
Cavalcoli JD; Baghian A; Homa FL; Kousoulas KG
Virology; 1993 Nov; 197(1):23-34. PubMed ID: 8212558
[TBL] [Abstract][Full Text] [Related]
5. Replacement of glycoprotein B gene in the herpes simplex virus type 1 strain ANGpath DNA by that originating from nonpathogenic strain KOS reduces the pathogenicity of recombinant virus.
Kostál M; Bacík I; Rajcáni J; Kaerner HC
Acta Virol; 1994 Apr; 38(2):77-88. PubMed ID: 7976866
[TBL] [Abstract][Full Text] [Related]
6. Herpes simplex virus type 1 VP26 is not essential for replication in cell culture but influences production of infectious virus in the nervous system of infected mice.
Desai P; DeLuca NA; Person S
Virology; 1998 Jul; 247(1):115-24. PubMed ID: 9683577
[TBL] [Abstract][Full Text] [Related]
7. Construction and characterization of a glycoprotein E gene-deleted bovine herpesvirus type 1 recombinant.
Chowdhury SI; Ross CS; Lee BJ; Hall V; Chu HJ
Am J Vet Res; 1999 Feb; 60(2):227-32. PubMed ID: 10048557
[TBL] [Abstract][Full Text] [Related]
8. Pathogenic potentials of glycoprotein C-negative syncytial mutants from rabbit T cells infected persistently with herpes simplex virus type 1.
Ishida Y; Okabe T; Azukizawa Y; Isono T; Seto A
J Med Virol; 2005 May; 76(1):89-97. PubMed ID: 15779044
[TBL] [Abstract][Full Text] [Related]
9. Two novel single amino acid syncytial mutations in the carboxy terminus of glycoprotein B of herpes simplex virus type 1 confer a unique pathogenic phenotype.
Engel JP; Boyer EP; Goodman JL
Virology; 1993 Jan; 192(1):112-20. PubMed ID: 8390747
[TBL] [Abstract][Full Text] [Related]
10. Genetic engineering of herpes simplex virus and vector genomes carrying loxP sites in cells expressing Cre recombinase.
Logvinoff C; Epstein AL
Virology; 2000 Feb; 267(1):102-10. PubMed ID: 10648187
[TBL] [Abstract][Full Text] [Related]
11. Second-site mutations encoding residues 34 and 78 of the major capsid protein (VP5) of herpes simplex virus type 1 are important for overcoming a blocked maturation cleavage site of the capsid scaffold proteins.
Warner SC; Desai P; Person S
Virology; 2000 Dec; 278(1):217-26. PubMed ID: 11112496
[TBL] [Abstract][Full Text] [Related]
12. A dominant mutant form of the herpes simplex virus ICP8 protein decreases viral late gene transcription.
Chen YM; Knipe DM
Virology; 1996 Jul; 221(2):281-90. PubMed ID: 8661438
[TBL] [Abstract][Full Text] [Related]
13. Increased transcomplementation properties of plasmids carrying HSV-1 origin of replication and packaging signals.
Berthomme H; Fournel S; Epstein AL
Virology; 1996 Feb; 216(2):437-43. PubMed ID: 8607275
[TBL] [Abstract][Full Text] [Related]
14. Human natural killer cell recognition of herpes simplex virus type 1 glycoproteins: specificity analysis with the use of monoclonal antibodies and antigenic variants.
Bishop GA; Marlin SD; Schwartz SA; Glorioso JC
J Immunol; 1984 Oct; 133(4):2206-14. PubMed ID: 6206157
[TBL] [Abstract][Full Text] [Related]
15. Modified entry and syncytium formation by herpes simplex virus type 1 mutants selected for resistance to heparin inhibition.
Pertel PE; Spear PG
Virology; 1996 Dec; 226(1):22-33. PubMed ID: 8941319
[TBL] [Abstract][Full Text] [Related]
16. Herpes simplex virus 1 protein kinase Us3 phosphorylates viral envelope glycoprotein B and regulates its expression on the cell surface.
Kato A; Arii J; Shiratori I; Akashi H; Arase H; Kawaguchi Y
J Virol; 2009 Jan; 83(1):250-61. PubMed ID: 18945776
[TBL] [Abstract][Full Text] [Related]
17. Positron emission tomography-based imaging of transgene expression mediated by replication-conditional, oncolytic herpes simplex virus type 1 mutant vectors in vivo.
Jacobs A; Tjuvajev JG; Dubrovin M; Akhurst T; Balatoni J; Beattie B; Joshi R; Finn R; Larson SM; Herrlinger U; Pechan PA; Chiocca EA; Breakefield XO; Blasberg RG
Cancer Res; 2001 Apr; 61(7):2983-95. PubMed ID: 11306477
[TBL] [Abstract][Full Text] [Related]
18. Identification of the fusion-from-without determinants of herpes simplex virus type 1 glycoprotein B.
Saharkhiz-Langroodi A; Holland TC
Virology; 1997 Jan; 227(1):153-9. PubMed ID: 9007068
[TBL] [Abstract][Full Text] [Related]
19. Herpes simplex virus 1 ICP27 is required for transcription of two viral late (gamma 2) genes in infected cells.
Jean S; LeVan KM; Song B; Levine M; Knipe DM
Virology; 2001 May; 283(2):273-84. PubMed ID: 11336552
[TBL] [Abstract][Full Text] [Related]
20. Mutated forms of human cytomegalovirus glycoprotein B are impaired in inducing syncytium formation.
Tugizov S; Wang Y; Qadri I; Navarro D; Maidji E; Pereira L
Virology; 1995 Jun; 209(2):580-91. PubMed ID: 7778290
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
